The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 19, 2017
Filed:
Apr. 04, 2012
Applicants:
Keisuke Ishii, Tokyo, JP;
Katsuyuki Mitomo, Tokyo, JP;
Katsushi Kouda, Tokyo, JP;
Fumiko Nomura, Tokyo, JP;
Yoko Kayukawa, Tokyo, JP;
Tadashi Matsuura, Tokyo, JP;
Inventors:
Keisuke Ishii, Tokyo, JP;
Katsuyuki Mitomo, Tokyo, JP;
Katsushi Kouda, Tokyo, JP;
Fumiko Nomura, Tokyo, JP;
Yoko Kayukawa, Tokyo, JP;
Tadashi Matsuura, Tokyo, JP;
Assignee:
PERSEUS PROTEOMICS INC., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 47/48 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48569 (2013.01); A61K 47/48584 (2013.01); A61K 47/48676 (2013.01); A61K 47/48715 (2013.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C07K 16/3015 (2013.01); C07K 2317/565 (2013.01);
Abstract
It is an object of the present invention to provide a drug conjugate comprising an anti-CDH3 antibody that efficiently kills cancer cells expressing CDH3. According to the present invention, there is provided an immune complex formed by binding an antibody against CDH3 or a fragment thereof having CDH3 binding ability to a chemotherapeutic agent.